27 results
8-K
CLNN
Clene Inc
19 Sep 23
Departure of Directors or Certain Officers
8:22am
of the Nominating and Corporate Governance Committee of the Board, appointed Professor Matthew Kiernan AM, Ph.D., DSc, and Arjun (JJ) Desai, M.D., as members
424B3
m33p8
11 Aug 21
Prospectus supplement
4:01pm
424B3
thxmb0o
11 Aug 21
Prospectus supplement
4:00pm
8-K
5e5gp5
9 Aug 21
Clene Nanomedicine Appoints Dr. Vallerie McLaughlin to its Board of Directors
4:07pm
424B3
lt1xz11qc1qyilk
2 Aug 21
Prospectus supplement
5:03pm
424B3
9ppvsvhk
12 May 21
Prospectus supplement
4:43pm
8-K
hv6sqvbs q5ta
22 Apr 21
Departure of Directors or Certain Officers
12:00am
424B3
ykf o1sob2e721uk
21 Apr 21
Prospectus supplement
6:04am
DEF 14A
pnsl7k5cyxcpyr
5 Apr 21
Definitive proxy
12:00am
10-K
dobo51ss 7u2z6hv3hsl
29 Mar 21
Annual report
12:00am
PRE 14A
eyjz7rkmf6zrjayd16gp
18 Mar 21
Preliminary proxy
4:33pm
S-1
xkqx vhjfl
17 Feb 21
IPO registration
12:00am
8-K
97wn9nrymnnq
5 Jan 21
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
5:18pm
424B3
c26u0w9tejoh
18 Dec 20
Prospectus supplement
2:24pm